Novartis Global Scholars Program (NGSP)

Novartis Global Scholars Program (NGSP) is sponsored by Novartis Biomedical Research. The Novartis Global Scholars Program is a competitive program for innovators from invited institutions to receive funding for breakthrough science not covered by traditional grant support.

Novartis Global Scholars Program | Novartis Novartis Global Scholars Program The Novartis Global Scholars Program (NGSP) is a competitive program designed for innovators from invited institutions to gain funding for breakthrough science not covered by traditional grant support.

Through this program, Novartis Biomedical Research supports projects focused on novel science with the objective of being translated to drug discovery and/or clinical research. Resources for breakthrough science Each Scholar will receive up to 1 mil USD funding over three years along with drug-hunting expertise from dedicated Biomedical Research scientific collaborators.

In addition, a dedicated alliance manager will ensure a productive collaboration environment between Novartis and the academic institution by handling all operational facets of the NGSP. Access to inter-disciplinary expertise Academic scholars have access to disease biology, drug-hunting and translational research expertise.

Each selected scholar will join forces with other entrepreneurially motivated Novartis Biomedical Research scientists to challenge the status quo and take bold risks for potential big rewards and will have an opportunity to advance research into early development stages.

Meet the 2023 recipients of the Novartis Global Scholars Program With these distinguished scholars, we will focus on innovative medicines to address the worldwide burden of disease.

Carlo Rinaldi (University of Oxford) Jess Cardin (Yale University) Julian Downward (Francis Crick Institute) Lars Fugger (University of Oxford) Oliver Distler (University of Zurich) Aravind Asokan (Duke University) Brent Ferrell (Vanderbilt University Medical Center) Hidetoshi Masumoto (Kyoto University) Magdalini Polymenidou (University of Zurich) Sereina Riniker (ETH Zurich) Jeffrey Bode (ETH Zurich) Paul Bowness (University of Oxford) Stephanie Dakin (University of Oxford) Christoph Rademacher (University of Vienna) David Andrews (Sunnybrook Research Institute) Matthew Greenblatt (Weill Cornell Medicine) Junyeop Lee (Asan Medical Center) Alison Narayan (University of Michigan) Ellis Reinherz (Dana-Farber Cancer Institute) Jin Zhang (University of California, San Diego) 60 world-class institutions are participating in NGSP 2023 The following institutions have been invited to participate in the 2023 NGSP.

We look forward to receiving their investigators’ proposals for innovative projects that will advance our mission to improve and extend peoples’ lives.

Academic Institution Academic Institution Medical University Vienna AT Seoul National University Hospital KR University of Vienna AT Instituto de Medicina Molecular PT Monash University AU Boston University US University of Melbourne AU Brigham and Women’s Hospital US UniQuest AU Columbia University US WEHI (Walter & Eliza Hall Inst.)

AU Weill Cornell Medicine US Sunnybrook Research Institute CA Duke University US The Hospital for Sick Children CA Emory University US University of Toronto CA Fred Hutchinson Cancer Research Center US ETH Zurich CH Mass Eye and Ear US University of Basel CH Massachusetts General Hospital US University of Geneva CH Morehouse School of Medicine US Geneva University Hospitals CH Northwestern University US University of Zurich CH Ohio State University US LMU Munich DE Rutgers, The State University of New Jersey US University Hospital Munich DE Schepens Eye Research Institute of Mass Eye and Ear US Institut Pasteur FR Temple University US Francis Crick Institute GB Tufts University US Imperial College London GB University of California, Los Angeles US University of Birmingham GB University of California, Berkeley US University of Cambridge GB University of California, San Diego US University of Oxford GB University of North Carolina at Chapel Hill US Council of Scientific & Industrial Research - Centre for Cellular and Molecular Biology (CSIR-CCMB) IN University of Arizona US Tel Aviv University IS University of Chicago US Weizmann Institute of Science IS University of Massachusetts Chan Medical School US Kyoto University JP University of Michigan US Okinawa Institute of Science and Technology JP University of Pittsburgh US Osaka University JP Vanderbilt University US University of Tokyo JP Washington University in St.

Louis US Asan Medical Center KR Yale University US Share Post Share Whatsapp Linkedin Email